We are a bioincubator helping emerging biotechs decreasing their time to seed funding.

We have a growing commitment to engineering innovation that improves industrial efficiency.

latest news older news

inOvO is looking for a Business Developer

inOvO, an in-creation UMONS spin-off, developing innovative endocrine disruptors detection tests is looking for a Business Developer. Interested ? Discover the full mission description here

Read more

iTeos Therapeutics Completes $75 Million Series B Financing

Gosselies, Belgium – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced the completion of an oversubscribed $75 million (€64 million) Series B financing led by MPM Capital, with participation from additional new investors HBM Partners, 6 Dimensions Capital and Curative Ventures. All existing investors also participated in this financing round including Fund +, VIVES II and SRIW, as well as SFPI. Read the official press release here.

Read more
Learn more about our events all events next event

MedTech Booster

Market opportunity validation

This one day booster aims at advising early stage MedTech projects on how to conduct a professional market validation...

Read more